Company intelligence / Profile preview

Transseptal Solutions

Massachusetts, United Statestransseptalsolutions.com ↗

Ownership: Private
Development stage: Commercial

Overview

The TSP Crosser system has received both FDA clearance and CE Mark approval. It has been used successfully in clinical procedures in the United States, demonstrating safe, accurate, and reproducible transseptal puncture for left atrial access. The system integrates a steerable sheath with a flexible needle and radiopaque loop wire to enhance procedural efficiency and safety during complex cardiac interventions.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Transseptal Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transseptal Solutions.

Explore the full profile